CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Morgan Stanley bullish on Galderma on stronger Nemluvio growth outlook

NemluvioPositive
AI Analysis

Summary

Morgan Stanley issued a bullish stance on Galderma citing stronger growth outlook for Nemluvio. The analyst note reflects positive sentiment on the drug's commercial performance.

Importance:3/10
Sentiment:
0.70
analyst_notebullishcommercial_outlook
Related Companies

Read the original article

Published by yahoo_finance on July 30, 2026 1:29 PM

Read Original